Assessment of ovarian failure and osteoporosis in premenopausal breast cancer survivors.
- Published in:
- Journal of Oncology Pharmacy Practice, 2005, v. 11, n. 2, p. 37, doi. 10.1191/1078155205jp144oa
- By:
- Publication type:
- Article
Works matching IS 10781552 AND DT 2005 AND VI 11 AND IP 2
Results: 7
1
2
Pharmaceutical validation as a process of improving the quality of antineoplastic treatment.
- Published in:
- Journal of Oncology Pharmacy Practice, 2005, v. 11, n. 2, p. 45, doi. 10.1191/1078155205jp156oa
- By:
- Publication type:
- Article
3
Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2005, v. 11, n. 2, p. 51, doi. 10.1191/1078155205jp145oa
- By:
- Publication type:
- Article
4
Sterility validity period of vials after multiple sampling under vertical laminar airflow hood.
- Published in:
- Journal of Oncology Pharmacy Practice, 2005, v. 11, n. 2, p. 57, doi. 10.1191/1078155205jp153oa
- By:
- Publication type:
- Article
5
A reporting system for the assessment of chemotherapy toxicity.
- Published in:
- Journal of Oncology Pharmacy Practice, 2005, v. 11, n. 2, p. 63, doi. 10.1191/1078155205jp154oa
- By:
- Publication type:
- Article
6
Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2005, v. 11, n. 2, p. 69, doi. 10.1191/1078155205jp155oa
- By:
- Publication type:
- Article
7
Vinorelbine and venous irritation: optimal parenteral administration.
- Published in:
- Journal of Oncology Pharmacy Practice, 2005, v. 11, n. 2, p. 79, doi. 10.1191/1078155205jp146oa
- By:
- Publication type:
- Article